Figure 3
Ofatumumab infusion–related reactions over the course of treatment. All patients received ofatumumab 300 mg for course 1. All infusion reactions on the day of ofatumumab infusion were CTC grade 1 or 2 events.
Ofatumumab infusion–related reactions over the course of treatment. All patients received ofatumumab 300 mg for course 1. All infusion reactions on the day of ofatumumab infusion were CTC grade 1 or 2 events.
